Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 181

1.

Can the interplay between androgen signaling and PSMA expression be leveraged for theranostic applications?

Batra JS, Pienta KJ, Pomper MG, Gorin MA, Rowe SP.

Transl Androl Urol. 2019 Jul;8(Suppl 3):S263-S264. doi: 10.21037/tau.2019.03.13. No abstract available.

2.

Imager-4D: New Software for Viewing Dynamic PET Scans and Extracting Radiomic Parameters from PET Data.

Rowe SP, Solnes LB, Yin Y, Kitchen G, Lodge MA, Karakatsanis NA, Rahmim A, Pomper MG, Leal JP.

J Digit Imaging. 2019 Aug 6. doi: 10.1007/s10278-019-00255-7. [Epub ahead of print]

PMID:
31388864
3.

The application of cinematic rendering to CT evaluation of upper tract urothelial tumors: principles and practice.

Rowe SP, Chu LC, Meyer AR, Gorin MA, Fishman EK.

Abdom Radiol (NY). 2019 Jul 31. doi: 10.1007/s00261-019-02154-5. [Epub ahead of print] Review.

PMID:
31367896
4.

Enhancing CAR T-cell therapy through cellular imaging and radiotherapy.

Minn I, Rowe SP, Pomper MG.

Lancet Oncol. 2019 Aug;20(8):e443-e451. doi: 10.1016/S1470-2045(19)30461-9. Epub 2019 Jul 29. Review.

PMID:
31364596
5.

A pilot study of prostate-specific membrane antigen (PSMA) dynamics in men undergoing treatment for advanced prostate cancer.

Paller CJ, Piana D, Eshleman JR, Riel S, Denmeade SR, Isaacsson Velho P, Rowe SP, Pomper MG, Antonarakis ES, Luo J, Eisenberger MA.

Prostate. 2019 Jul 30. doi: 10.1002/pros.23883. [Epub ahead of print]

PMID:
31361358
6.

Nivolumab-Associated Pulmonary and Bone Sarcoidosis in a Patient With Melanoma of Unknown Primary.

Tulbah RI, Rowe SP, Solnes LB, Javadi MS.

Clin Nucl Med. 2019 Sep;44(9):e519-e521. doi: 10.1097/RLU.0000000000002724.

PMID:
31348077
7.

Impact of aging on semiquantitative uptake parameters in normal rated clinical baseline [123I]Ioflupane single photon emission computed tomography/computed tomography.

Werner RA, Lapa C, Sheikhbahaei S, Marcus C, Solnes LB, Du Y, Leal JP, Buck AK, Higuchi T, Rowe SP, Javadi MS.

Nucl Med Commun. 2019 Jul 22. doi: 10.1097/MNM.0000000000001061. [Epub ahead of print]

PMID:
31343608
8.

Initial Evaluation of AF78: a Rationally Designed Fluorine-18-Labelled PET Radiotracer Targeting Norepinephrine Transporter.

Chen X, Fritz A, Werner RA, Nose N, Yagi Y, Kimura H, Rowe SP, Koshino K, Decker M, Higuchi T.

Mol Imaging Biol. 2019 Jul 22. doi: 10.1007/s11307-019-01407-5. [Epub ahead of print]

PMID:
31332629
9.

Recent Updates on Molecular Imaging Reporting and Data Systems (MI-RADS) for Theranostic Radiotracers-Navigating Pitfalls of SSTR- and PSMA-Targeted PET/CT.

Werner RA, Thackeray JT, Pomper MG, Bengel FM, Gorin MA, Derlin T, Rowe SP.

J Clin Med. 2019 Jul 19;8(7). pii: E1060. doi: 10.3390/jcm8071060. Review.

10.

Stability of Distribution of F18 Flurpiridaz After Transient Coronary Occlusion in Pigs.

Werner RA, Koshino K, Arimitsu K, Lapa C, Javadi MS, Rowe SP, Nose N, Kimura H, Fukushima K, Higuchi T.

JACC Cardiovasc Imaging. 2019 Jul 11. pii: S1936-878X(19)30537-6. doi: 10.1016/j.jcmg.2019.05.018. [Epub ahead of print] No abstract available.

PMID:
31326498
11.

Imaging CAR T cell therapy with PSMA-targeted positron emission tomography.

Minn I, Huss DJ, Ahn HH, Chinn TM, Park A, Jones J, Brummet M, Rowe SP, Sysa-Shah P, Du Y, Levitsky HI, Pomper MG.

Sci Adv. 2019 Jul 3;5(7):eaaw5096. doi: 10.1126/sciadv.aaw5096. eCollection 2019 Jul.

12.

[68Ga]-Pentixafor PET/CT for CXCR4-Mediated Imaging of Vestibular Schwannomas.

Breun M, Monoranu CM, Kessler AF, Matthies C, Löhr M, Hagemann C, Schirbel A, Rowe SP, Pomper MG, Buck AK, Wester HJ, Ernestus RI, Lapa C.

Front Oncol. 2019 Jun 12;9:503. doi: 10.3389/fonc.2019.00503. eCollection 2019.

13.

Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer: An Update on Important Pitfalls.

Sheikhbahaei S, Werner RA, Solnes LB, Pienta KJ, Pomper MG, Gorin MA, Rowe SP.

Semin Nucl Med. 2019 Jul;49(4):255-270. doi: 10.1053/j.semnuclmed.2019.02.006. Epub 2019 Mar 4. Review.

PMID:
31227049
14.

Preoperative PSMA-targeted PET imaging: more than just a tool for prostate cancer staging?

Meyer AR, Rowe SP, Gorin MA.

BJU Int. 2019 Jul;124(1):2-3. doi: 10.1111/bju.14624. No abstract available.

PMID:
31207000
15.

Prospective Evaluation of PSMA-Targeted 18F-DCFPyL PET/CT in Men with Biochemical Failure after Radical Prostatectomy for Prostate Cancer.

Rowe SP, Campbell SP, Mana-Ay M, Szabo Z, Allaf ME, Pienta KJ, Pomper MG, Ross AE, Gorin MA.

J Nucl Med. 2019 Jun 14. pii: jnumed.119.226514. doi: 10.2967/jnumed.119.226514. [Epub ahead of print]

PMID:
31201249
16.

Improved identification of patients with oligometastatic clear cell renal cell carcinoma with PSMA-targeted 18F-DCFPyL PET/CT.

Meyer AR, Carducci MA, Denmeade SR, Markowski MC, Pomper MG, Pierorazio PM, Allaf ME, Rowe SP, Gorin MA.

Ann Nucl Med. 2019 Aug;33(8):617-623. doi: 10.1007/s12149-019-01371-8. Epub 2019 May 30.

PMID:
31147927
17.

The next era of renal radionuclide imaging: novel PET radiotracers.

Werner RA, Chen X, Lapa C, Koshino K, Rowe SP, Pomper MG, Javadi MS, Higuchi T.

Eur J Nucl Med Mol Imaging. 2019 Aug;46(9):1773-1786. doi: 10.1007/s00259-019-04359-8. Epub 2019 May 30.

18.

Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Impact of Tumor Burden on Normal Organ Uptake.

Werner RA, Bundschuh RA, Bundschuh L, Lapa C, Yin Y, Javadi MS, Buck AK, Higuchi T, Pienta KJ, Pomper MG, Lodge MA, Gorin MA, Rowe SP.

Mol Imaging Biol. 2019 May 28. doi: 10.1007/s11307-019-01375-w. [Epub ahead of print]

PMID:
31140110
19.

From the Reading Room to the Courtroom-The Use of Molecular Radionuclide Imaging in Criminal Trials.

Werner RA, Savoie B, Javadi MS, Pomper MG, Higuchi T, Lapa C, Rowe SP.

J Am Coll Radiol. 2019 May 24. pii: S1546-1440(19)30567-8. doi: 10.1016/j.jacr.2019.05.001. [Epub ahead of print]

PMID:
31132333
20.

Cinematic rendering of skin and subcutaneous soft tissues: potential applications in acute trauma.

Chu LC, Rowe SP, Fishman EK.

Emerg Radiol. 2019 May 25. doi: 10.1007/s10140-019-01697-w. [Epub ahead of print]

PMID:
31129738
21.

The Value of Reputation: Understanding the Current Marketing Ecosystem for Content Producers.

Grossman KA, Fishman EK, Horton KM, Rowe SP.

J Am Coll Radiol. 2019 May 21. pii: S1546-1440(19)30528-9. doi: 10.1016/j.jacr.2019.04.021. [Epub ahead of print] No abstract available.

PMID:
31125540
22.

Relationship between DXA measured metrics of adiposity and glucose homeostasis; An analysis of the NHANES data.

Santhanam P, Rowe SP, Dias JP, Ahima RS.

PLoS One. 2019 May 22;14(5):e0216900. doi: 10.1371/journal.pone.0216900. eCollection 2019.

23.

Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Intrapatient and Interpatient Variability of Normal Organ Uptake.

Sahakyan K, Li X, Lodge MA, Werner RA, Bundschuh RA, Bundschuh L, Kulkarni HR, Schuchardt C, Baum RP, Pienta KJ, Pomper MG, Ross AE, Gorin MA, Rowe SP.

Mol Imaging Biol. 2019 May 21. doi: 10.1007/s11307-019-01376-9. [Epub ahead of print]

PMID:
31115751
24.

Response to R-CHOP in HPV-related squamous cell carcinoma of base of tongue: a case report.

Ma TM, Kang H, Rowe SP, Kiess AP.

Cancers Head Neck. 2018 May 24;3:2. doi: 10.1186/s41199-018-0028-6. eCollection 2018.

25.

No Mission, No Engagement.

Fishman EK, Chu LC, Rowe SP.

J Am Coll Radiol. 2019 May 16. pii: S1546-1440(19)30454-5. doi: 10.1016/j.jacr.2019.04.012. [Epub ahead of print] No abstract available.

PMID:
31092341
26.

Computed Tomography Cinematic Rendering in the Evaluation of Colonic Pathology: Technique and Clinical Applications.

Rowe SP, Chu LC, Fishman EK.

J Comput Assist Tomogr. 2019 May/Jun;43(3):475-484. doi: 10.1097/RCT.0000000000000864. Review.

PMID:
31082955
27.

Cinematic rendering of focal liver masses.

Chu LC, Rowe SP, Fishman EK.

Diagn Interv Imaging. 2019 Apr 29. pii: S2211-5684(19)30091-9. doi: 10.1016/j.diii.2019.04.003. [Epub ahead of print]

PMID:
31047840
28.

Soft Tissue Calcinosis Universalis Visualized with Novel 3-D Computed Tomography Cinematic Rendering.

Rowe SP, Fritz J, Fishman EK.

J Rheumatol. 2019 May;46(5):539-540. doi: 10.3899/jrheum.180208. No abstract available.

PMID:
31043499
29.

Learning to Talk Again in a Voice-First World.

Isbitski D, Fishman EK, Horton KM, Rowe SP.

J Am Coll Radiol. 2019 Aug;16(8):1123-1124. doi: 10.1016/j.jacr.2019.01.034. Epub 2019 Apr 13. No abstract available.

PMID:
30987902
30.

3D CT cinematic rendering of the spleen: Potential role in problem solving.

Rowe SP, Chu LC, Fishman EK.

Diagn Interv Imaging. 2019 Mar 27. pii: S2211-5684(19)30062-2. doi: 10.1016/j.diii.2019.03.005. [Epub ahead of print]

PMID:
30928470
31.

Cinematic Rendering of Neurofibromatosis Type I Gastrointestinal Stromal Tumors.

Rowe SP, Fishman EK.

Radiology. 2019 May;291(2):298. doi: 10.1148/radiol.2019190104. Epub 2019 Mar 19. No abstract available.

PMID:
30888936
32.

18F-NaF-PET/CT for the detection of bone metastasis in prostate cancer: a meta-analysis of diagnostic accuracy studies.

Sheikhbahaei S, Jones KM, Werner RA, Salas-Fragomeni RA, Marcus CV, Higuchi T, Rowe SP, Solnes LB, Javadi MS.

Ann Nucl Med. 2019 May;33(5):351-361. doi: 10.1007/s12149-019-01343-y. Epub 2019 Mar 15.

PMID:
30877561
33.

Recent paradigm shifts in molecular cardiac imaging-Establishing precision cardiology through novel 18F-labeled PET radiotracers.

Werner RA, Chen X, Rowe SP, Lapa C, Javadi MS, Higuchi T.

Trends Cardiovasc Med. 2019 Feb 20. pii: S1050-1738(19)30025-8. doi: 10.1016/j.tcm.2019.02.007. [Epub ahead of print] Review.

34.

Novel Structured Reporting Systems for Theranostic Radiotracers.

Werner RA, Bundschuh RA, Bundschuh L, Fanti S, Javadi MS, Higuchi T, Weich A, Pienta KJ, Buck AK, Pomper MG, Gorin MA, Herrmann K, Lapa C, Rowe SP.

J Nucl Med. 2019 May;60(5):577-584. doi: 10.2967/jnumed.118.223537. Epub 2019 Feb 22.

PMID:
30796171
35.

Hereditary Spherocytosis Presenting as Diffuse Bone Marrow Activation and Splenomegaly on PSMA-Targeted 18F-DCFPyL PET/CT.

Gomez E, Tran PT, Pienta KJ, Pomper MG, Gorin MA, Rowe SP.

Clin Nucl Med. 2019 Apr;44(4):e313-e314. doi: 10.1097/RLU.0000000000002489.

PMID:
30789396
36.

Novel Functional Renal PET Imaging With 18F-FDS in Human Subjects.

Werner RA, Ordonez AA, Sanchez-Bautista J, Marcus C, Lapa C, Rowe SP, Pomper MG, Leal JP, Lodge MA, Javadi MS, Jain SK, Higuchi T.

Clin Nucl Med. 2019 May;44(5):410-411. doi: 10.1097/RLU.0000000000002494.

PMID:
30762825
37.

PSMA-targeted [18F]DCFPyL PET/CT-avid lesions in a patient with prostate cancer: Clinical decision-making informed by the PSMA-RADS interpretive framework.

Reyes DK, Demehri S, Werner RA, Pomper MG, Gorin MA, Rowe SP, Pienta KJ.

Urol Case Rep. 2019 Jan 9;23:72-74. doi: 10.1016/j.eucr.2019.01.007. eCollection 2019 Mar.

38.

Imaging of Prostate-Specific Membrane Antigen with Small-Molecule PET Radiotracers: From the Bench to Advanced Clinical Applications.

Rowe SP, Gorin MA, Pomper MG.

Annu Rev Med. 2019 Jan 27;70:461-477. doi: 10.1146/annurev-med-062117-073027.

PMID:
30691373
39.

Three-dimensional computed tomography cinematic rendering of mandibular odontogenic myxofibroma.

Rowe SP, Fishman EK.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2019 Jan 2. pii: S2212-4403(18)31348-8. doi: 10.1016/j.oooo.2018.12.022. [Epub ahead of print]

PMID:
30665843
40.

The theranostic promise for Neuroendocrine Tumors in the late 2010s - Where do we stand, where do we go?

Werner RA, Weich A, Kircher M, Solnes LB, Javadi MS, Higuchi T, Buck AK, Pomper MG, Rowe SP, Lapa C.

Theranostics. 2018 Nov 29;8(22):6088-6100. doi: 10.7150/thno.30357. eCollection 2018. Review.

41.

Generative Adversarial Networks for the Creation of Realistic Artificial Brain Magnetic Resonance Images.

Kazuhiro K, Werner RA, Toriumi F, Javadi MS, Pomper MG, Solnes LB, Verde F, Higuchi T, Rowe SP.

Tomography. 2018 Dec;4(4):159-163. doi: 10.18383/j.tom.2018.00042.

42.

Noninvasive 11C-rifampin positron emission tomography reveals drug biodistribution in tuberculous meningitis.

Tucker EW, Guglieri-Lopez B, Ordonez AA, Ritchie B, Klunk MH, Sharma R, Chang YS, Sanchez-Bautista J, Frey S, Lodge MA, Rowe SP, Holt DP, Gobburu JVS, Peloquin CA, Mathews WB, Dannals RF, Pardo CA, Kannan S, Ivaturi VD, Jain SK.

Sci Transl Med. 2018 Dec 5;10(470). pii: eaau0965. doi: 10.1126/scitranslmed.aau0965.

PMID:
30518610
43.

Simplifying Complexity: Lessons for Radiology From a New Type of Stock Exchange.

Lam G, Fishman EK, Horton KM, Rowe SP.

J Am Coll Radiol. 2019 Apr;16(4 Pt A):536-538. doi: 10.1016/j.jacr.2018.09.046. Epub 2018 Nov 14. No abstract available.

PMID:
30447933
44.

Molecular Imaging for Evaluation of Viable Testicular Cancer Nodal Metastases.

Joice GA, Rowe SP, Gorin MA, Pierorazio PM.

Curr Urol Rep. 2018 Nov 9;19(12):110. doi: 10.1007/s11934-018-0863-3. Review.

PMID:
30413968
45.

Impact of Tumor Burden on Quantitative [68Ga] DOTATOC Biodistribution.

Werner RA, Hänscheid H, Leal JP, Javadi MS, Higuchi T, Lodge MA, Buck AK, Pomper MG, Lapa C, Rowe SP.

Mol Imaging Biol. 2019 Aug;21(4):790-798. doi: 10.1007/s11307-018-1293-9.

PMID:
30406512
46.

Visual and Semiquantitative Accuracy in Clinical Baseline 123I-Ioflupane SPECT/CT Imaging.

Werner RA, Marcus C, Sheikhbahaei S, Solnes LB, Leal JP, Du Y, Rowe SP, Higuchi T, Buck AK, Lapa C, Javadi MS.

Clin Nucl Med. 2019 Jan;44(1):1-3. doi: 10.1097/RLU.0000000000002333.

PMID:
30371577
47.

Moving into the next era of PET myocardial perfusion imaging: introduction of novel 18F-labeled tracers.

Werner RA, Chen X, Rowe SP, Lapa C, Javadi MS, Higuchi T.

Int J Cardiovasc Imaging. 2019 Mar;35(3):569-577. doi: 10.1007/s10554-018-1469-z. Epub 2018 Oct 17. Review.

48.

Uptake of Prostate-Specific Membrane Antigen-Targeted 18F-DCFPyL in Cerebral Radionecrosis: Implications for Diagnostic Imaging of High-Grade Gliomas.

Salas Fragomeni RA, Pienta KJ, Pomper MG, Gorin MA, Rowe SP.

Clin Nucl Med. 2018 Nov;43(11):e419-e421. doi: 10.1097/RLU.0000000000002280.

PMID:
30247210
49.

3D CT cinematic rendering of mycotic aneurysms.

Rowe SP, Chu LC, Zimmerman SL, Fishman EK.

Emerg Radiol. 2018 Dec;25(6):723-728. doi: 10.1007/s10140-018-1643-6. Epub 2018 Sep 19.

PMID:
30232634
50.

Inconsistent Detection of Sites of Metastatic Non-Clear Cell Renal Cell Carcinoma with PSMA-Targeted [18F]DCFPyL PET/CT.

Yin Y, Campbell SP, Markowski MC, Pierorazio PM, Pomper MG, Allaf ME, Rowe SP, Gorin MA.

Mol Imaging Biol. 2019 Jun;21(3):567-573. doi: 10.1007/s11307-018-1271-2.

PMID:
30218388

Supplemental Content

Support Center